Table 2.
AJCC 2002 stage groupings for cutaneous melanoma (adapted from [1])
| Stage | Clinical stage grouping |
Pathologic stage grouping |
||||
| 0 | Tis | N0 | M0 | pTis | N0 | M0 |
| IA | T1a | N0 | M0 | pT1a | N0 | M0 |
| IB | T1b | N0 | M0 | pT1b | N0 | M0 |
| T2a | N0 | M0 | pT2a | N0 | M0 | |
| IIA | T2b | N0 | M0 | pT2b | N0 | M0 |
| T3a | N0 | M0 | pT3a | N0 | M0 | |
| IIB | T3b | N0 | M0 | pT3b | N0 | M0 |
| T4a | N0 | M0 | pT4a | N0 | M0 | |
| IIC | T4b | N0 | M0 | pT4b | N0 | M0 |
| III | Any T | N1–3 | M0 | |||
| IIIA | pT1–4a | N1a | M0 | |||
| pT1–4a | N2a | M0 | ||||
| IIIB | pT1–4b | N1a | M0 | |||
| pT1–4b | N2a | M0 | ||||
| pT1–4a | N1b | M0 | ||||
| pT1–4a | N2b | M0 | ||||
| pT1–4a/b | N2c | M0 | ||||
| pT1–4b | N1b | M0 | ||||
| IIIC | pT1–4b | N2b | M0 | |||
| Any T | N3 | M0 | ||||
| IV | Any T | Any N | M1 | Any T | Any N | M1 |